Issue 2/2021
Content (7 Articles)
Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2
Susanna Esposito, Nicola Principi
Paradoxical Psoriasis in Children Receiving Anti-TNFα Treatment for Inflammatory/autoimmune Disease
Natalie Rosenwasser, Dale Lee, Robert Sidbury, Yongdong Zhao
Clinical and Economic Evaluation of the Impact of Midazolam on Morphine Therapy for Pain Relief in Critically Ill Ventilated Infants with Respiratory Distress Syndrome
Dina Abushanab, Fouad F. Abounahia, Omar Alsoukhni, Mohammed Abdelaal, Daoud Al-Badriyeh
Haloperidol and Quetiapine for the Treatment of ICU-Associated Delirium in a Tertiary Pediatric ICU: A Propensity Score-Matched Cohort Study
Michael T. Cronin, Jane L. Di Gennaro, R. Scott Watson, Leslie A. Dervan
Prescribing Patterns and Impact of Factors Associated with Time to Initial Biologic Therapy among Children with Non-systemic Juvenile Idiopathic Arthritis
Xiaomeng Yue, Bin Huang, Ana L. Hincapie, Patricia R. Wigle, Tingting Qiu, Yuxiang Li, Esi M. Morgan, Jeff J. Guo
Is It Useful to Monitor Thiopurine Metabolites in Pediatric Patients with Crohn’s Disease on Combination Therapy? A Multicenter Prospective Observational Study
Kristyna Pospisilova, Jitka Siroka, Eva Karaskova, Ondrej Hradsky, Tereza Lerchova, Kristyna Zarubova, Ivana Copova, Lucie Gonsorcikova, Maria Velganova-Veghova, Irena Francova, Lubor Urbanek, Milos Geryk, Vladimir Mihal, Jiri Bronsky
Cardiovascular Drug Therapy during Interstage After Hybrid Approach: A Single-Center Experience in 51 Newborns with Hypoplastic Left Heart
Tino Mienert, Anoosh Esmaeili, Blanka Steinbrenner, Markus Khalil, Matthias Müller, Hakan Akintuerk, Gunter Kerst, Dietmar Schranz